Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
povidone-iodine + lidocaine hydrochloride + triamcinolone is a multi-component prescription injection kit used in procedural musculoskeletal and soft-tissue injection settings. It combines povidone-iodine for antiseptic skin preparation, lidocaine hydrochloride as an amide local anesthetic that blocks voltage-gated sodium channels to produce local or regional anesthesia, and triamcinolone acetonide as a synthetic glucocorticoid corticosteroid that activates the glucocorticoid receptor to suppress inflammatory signaling. The product has been marketed as **LIDOLOG KIT** and is associated with AuroMedics and Aurobindo for distribution/manufacture. The kit is intended for intramuscular and intra-articular or soft-tissue use in settings such as arthritis, bursitis, tenosynovitis, epicondylitis, synovitis of osteoarthritis, and other corticosteroid-responsive inflammatory disorders. It is a combination of established small-molecule actives rather than a novel molecular entity, and the available context indicates it is an unapproved drug product kit whose labeling has not been approved by the FDA.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on povidone-iodine + lidocaine hydrochloride + triamcinolone.